Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-13 5:25 pm Purchase | 13G | HARROW INC HROW | Kaufman Daniel Louis | 1,907,332 5.43% | 22,300 (+1.18%) | View |
2024-02-13 5:06 pm Purchase | 13G | HARROW INC HROW | VANGUARD GROUP INC | 1,808,552 5.15% | 1,808,552 (New Position) | View |
2024-02-09 4:05 pm Purchase | 13G | HARROW INC HROW | Opaleye Management Inc. | 3,820,000 10.88% | 45,000 (+1.19%) | View |
2024-01-29 3:26 pm Purchase | 13G | HARROW INC HROW | BlackRock Inc. BLK | 2,220,538 6.3% | 1,806,673 (+436.54%) | View |
2024-01-09 10:16 am Purchase | 13G | HARROW INC HROW | Private Capital Management LLC | 3,630,496 10.34% | 3,630,496 (New Position) | View |
2023-11-22 7:23 pm Purchase | 13G | HARROW INC HROW | Kaufman Daniel Louis | 1,885,032 5.37% | 1,885,032 (New Position) | View |
2023-08-18 4:42 pm Purchase | 13D | HARROW INC HROW | BAUM MARK L | 3,488,361 9.5% | 3,488,361 (New Position) | View |
2023-01-20 4:59 pm Purchase | 13G | HARROW INC HROW | Opaleye Management Inc. | 3,775,000 12.82% | 490,000 (+14.92%) | View |
2022-02-14 3:22 pm Purchase | 13G | HARROW INC HROW | Ophir Asset Management Pty Ltd | 1,905,354 7.08% | 1,905,354 (New Position) | View |
2022-02-10 4:32 pm Sale | 13G | HARROW INC HROW | RENAISSANCE TECHNOLOGIES LLC | 1,199,112 4.46% | -294,100 (-19.70%) | View |
2022-01-28 4:05 pm Sale | 13D | ETON PHARMACEUTICALS INC ETON | HARROW INC. HROW | 1,982,000 8.1% | -1,518,000 (-43.37%) | View |
2022-01-25 9:43 pm Purchase | 13G | HARROW INC HROW | Opaleye Management Inc. | 3,285,000 12.2% | 219,584 (+7.16%) | View |
2021-07-12 08:29 am Sale | 13G | HARROW INC HROW | BlackRock Inc. BLK | 413,865 1.6% | -1,118,799 (-73.00%) | View |
2021-04-27 5:25 pm Purchase | 13D | IMPRIMIS PHARMACEUTICALS, INC. IMMY | BAUM MARK L | 2,367,072 8.6% | 897,662 (+61.09%) | View |
2021-02-12 5:20 pm Purchase | 13G | HARROW INC HROW | Opaleye Management Inc. | 3,065,416 11.91% | 3,065,416 (New Position) | View |
2021-02-10 11:01 am Purchase | 13G | HARROW INC HROW | RENAISSANCE TECHNOLOGIES LLC | 1,493,212 5.8% | 1,493,212 (New Position) | View |
2021-02-02 3:13 pm Purchase | 13G | HARROW INC HROW | BlackRock Inc. BLK | 1,532,664 6% | 1,532,664 (New Position) | View |
2020-05-26 11:09 am Sale | 13G | ETON PHARMACEUTICALS INC ETON | Opaleye Management Inc. | 2,625,000 10.27% | -1,015,000 (-27.88%) | View |
2020-02-14 4:30 pm Purchase | 13G | ETON PHARMACEUTICALS INC ETON | Opaleye Management Inc. | 2,340,000 9.3% | 870,544 (+59.24%) | View |